ADC Therapeutics S.A.

NYSE: ADCT · Real-Time Price · USD
3.13
-0.06 (-1.88%)
At close: Aug 15, 2025, 3:59 PM
3.13
-0.04%
After-hours: Aug 15, 2025, 06:42 PM EDT

ADC Therapeutics S.A. Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-149.84M -157.85M -212.82M -216.66M -227.23M -240.05M -178.51M -181.31M -198.56M -155.8M -166.02M -186.97M -195.16M -230.03M -251.57M -200.35M -254.34M
Depreciation & Amortization
3.23M 3.28M 3.49M 3.48M 3.42M 3.27M 2.83M 2.61M 2.43M 2.33M 2.51M 2.6M 2.65M 2.63M 2.69M 2.52M 2.32M
Stock-Based Compensation
8.83M 6.57M 6.5M 6.21M 5.58M 13.49M 19.48M 31.54M 44M 49.32M 55.24M 55.48M 59.93M 60.48M 62.43M 58.62M 47.75M
Other Working Capital
8.7M -1.4M 1.1M -1.14M 366K -979K -414K -1.06M 15.99M 18.4M 14.95M 17.83M 408K 5.2M 10.31M 5.47M 4.51M
Other Non-Cash Items
17.53M 30.63M 28.33M 32.39M 33.45M 23.23M 29.47M 60.51M 29.76M 1.07M -9.23M -39.9M -30.59M -24.7M -36.81M -81.29M 5.1M
Deferred Income Tax
n/a n/a 45.75M 45.17M 37.95M 37.1M -1.8M -782K 2.3M -708K -29.52M -29.82M -25.44M -21.48M 618K 470K 334K
Change in Working Capital
13.99M 4.07M 4.22M -4.1M 733K 44.27M -9.19M -14.07M 2.16M -33.01M 692K -8.5M -23.49M -20.28M -801K 10.83M 7.07M
Operating Cash Flow
-134.81M -122.57M -133.79M -142.77M -148.01M -118.69M -137.71M -101.5M -117.68M -136.79M -146.33M -207.11M -212.11M -233.38M -223.44M -209.2M -191.78M
Capital Expenditures
-590.8K -857.8K -1.09M -1.54M -2.73M -3.22M -3.01M -2.6M -2.2M -2.3M -2.71M -4.8M -6.84M -6.38M -6.62M -5.68M -2.99M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -200K -197.99K 2.01K -17.99K 180.06K 177.45K 97.45K -212.55K -507.6K -1.44M -3.46M -3.13M -2.85M -2.92M -999K
Investing Cash Flow
-590.8K -857.8K -1.29M -1.74M -2.73M -3.22M -2.81M -2.4M -2.08M -2.51M -3.22M -5.3M -7.46M -6.67M -6.64M -5.7M -2.99M
Debt Repayment
n/a n/a n/a -409K -409K -409K -2.34M 112.32M 112.32M 112.06M 113.75M -718K 48.66M 48.61M 48.63M 48.49M 61.73M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a -218.94K -218.94K -218.94K -218.94K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
98.19M 98.28M 101.04M 99.48M 73.89M 73.96M 72.08M -38.59M -111.94M -112.37M -113.12M 218.29M 218.78M 218.78M 219.82M 288K 244.21M
Financial Cash Flow
95.34M 95.43M 98.19M 96.76M 74.43M 73.88M 69.79M 74.46M -531K -593K 637K 217.58M 267.43M 267.39M 265.74M 237.78M 494.95M
Net Cash Flow
-39.58M -27.73M -36.13M -47.39M -76.26M -47.84M -70.45M -29.27M -120.33M -140.1M -149.33M 4.89M 47.75M 27.35M 35.78M 23.29M 300.55M
Free Cash Flow
-135.4M -123.43M -134.89M -144.31M -150.74M -121.9M -140.72M -104.1M -119.88M -139.09M -149.04M -211.91M -218.95M -239.75M -230.06M -214.88M -194.77M